Tikun Olam

Tikun Olam, whose name translates from Hebrew as “to heal the world,” operates as a pioneer in the medical cannabis market. The company was established in 2005 by Tzahi Cohen in Tel Aviv, Israel, initially as a non-profit organization. It began by openly cultivating and distributing cannabis for free to patients, including many veteran soldiers, who were suffering from various ailments. This grassroots effort helped build momentum for cannabis liberalization in Israel.

In 2007, the company achieved a significant milestone by becoming the first to be granted a license by the Israeli Ministry of Health to grow and supply medical marijuana. This marked a pivotal moment, transitioning Tikun Olam into a limited company in 2010 following regulatory changes. The business model centers on the cultivation, research, development, and distribution of proprietary, genetically optimized cannabis strains designed for specific symptomatic relief. Revenue is generated through the sale of its medical cannabis products and by exporting its know-how and intellectual property to international partners in exchange for royalties and stakes in joint ventures. This strategy has led to a global presence with operations in the United States, Canada, Australia, and Europe.

Tikun Olam serves medical patients suffering from a wide range of conditions, including cancer, PTSD, Crohn's disease, colitis, epilepsy, and multiple sclerosis. The company's product line is extensive, including cannabis flower, pre-rolls, oils, tinctures, edibles, and topicals. A key achievement came in 2012 when Tikun Olam developed 'Avidekel,' a strain with high cannabidiol (CBD) content and minimal psychoactive THC, which garnered international media attention. This product allows patients to receive the therapeutic benefits of cannabis without the intoxicating effects. The company has built one of the world's largest patient treatment databases, which it uses to inform strain development and patient care, collaborating with physicians, hospitals, and researchers. This commitment to research includes numerous peer-reviewed studies and clinical trials, solidifying its reputation among medical practitioners. Keywords: medical cannabis, cannabis research, proprietary strains, patient data, cannabis oil, CBD products, THC products, global cannabis, Israel cannabis, patient care, clinical trials, cannabis genetics, symptom relief, therapeutic cannabis, cannabis topicals, cannabis edibles, cannabis tinctures, plant-based medicine, Crohn's disease treatment, PTSD treatment